Monsanto Co. (NYSE:MON) EVP Robert T. Fraley sold 80,631 shares of the stock in a transaction dated Friday, October 14th. The stock was sold at an average price of $102.04, for a total value of $8,227,587.24. Following the completion of the sale, the executive vice president now directly owns 38,711 shares of the company’s stock, valued at $3,950,070.44. The sale was disclosed in a filing with the SEC, which is available at this link.
Monsanto Co. (NYSE:MON) opened at 102.11 on Monday. The firm has a 50-day moving average price of $104.39 and a 200 day moving average price of $101.78. Monsanto Co. has a 12 month low of $83.73 and a 12 month high of $114.26. The company has a market cap of $44.69 billion, a P/E ratio of 34.17 and a beta of 1.19.
Monsanto (NYSE:MON) last released its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.09. The firm had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.19) earnings per share. On average, equities analysts expect that Monsanto Co. will post $4.89 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be paid a $0.54 dividend. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 annualized dividend and a yield of 2.12%. Monsanto’s dividend payout ratio is 71.05%.
Hedge funds have recently added to or reduced their stakes in the stock. Virginia Retirement System purchased a new position in Monsanto during the first quarter valued at approximately $626,000. JPMorgan Chase & Co. increased its position in Monsanto by 2.3% in the first quarter. JPMorgan Chase & Co. now owns 828,673 shares of the company’s stock valued at $72,708,000 after buying an additional 18,961 shares during the last quarter. M&T Bank Corp increased its position in Monsanto by 16.4% in the first quarter. M&T Bank Corp now owns 77,720 shares of the company’s stock valued at $6,820,000 after buying an additional 10,927 shares during the last quarter. Carnick & Kubik LLC purchased a new position in Monsanto during the first quarter valued at approximately $130,000. Finally, Meiji Yasuda Asset Management Co Ltd. increased its position in Monsanto by 4.2% in the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 30,933 shares of the company’s stock valued at $2,714,000 after buying an additional 1,260 shares during the last quarter. Hedge funds and other institutional investors own 78.94% of the company’s stock.
MON has been the subject of a number of recent research reports. Goldman Sachs Group Inc. set a $92.00 price target on Monsanto and gave the stock a “sell” rating in a research note on Monday, June 27th. Vetr raised Monsanto from a “buy” rating to a “strong-buy” rating and set a $116.55 price target for the company in a research note on Monday, June 27th. Jefferies Group reaffirmed a “buy” rating on shares of Monsanto in a research note on Wednesday, June 29th. Deutsche Bank AG reaffirmed a “buy” rating and set a $118.00 price target on shares of Monsanto in a research note on Thursday, June 30th. Finally, Piper Jaffray Cos. cut their price target on Monsanto from $127.00 to $118.00 and set an “overweight” rating for the company in a research note on Thursday, June 30th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $114.65.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.